top-10-R-D
  1. Pharmaceutical companies depend largely on R & D to innovate new product for certain diseases to help in patients treatment and remove suffering
  2. 2020 is the year of highest budget in R & D in many pharmaceutical companies. Top 10 companies spent around $96 billion this year.
  3. COVID took the major uptake. Many R& D focused on COVID, but there were plenty in the more traditional areas such as cancer, and in more forgotten areas, like heart disease and antibiotics.
The following top 10 R & D spending companies and This spending as a percent of revenue:
  1. Roche R&D budget: ($13.9 billion) R&D budget as percentage of revenue: 22.2%
  2. Merck & Co. R&D budget: $13.6 billion R&D budget as percentage of revenue: 28.3%
  3.  Johnson & Johnson R&D budget: $12.15B R&D budget as percentage of revenue: 14.7%
  4. Bristol Myers Squibb R&D budget: $11.14 billion R&D budget as percentage of revenue: 26%
  5.  Pfizer R&D budget: $9.4 billion R&D budget as percentage of revenue: 22.4%
  6. Novartis R&D budget:$8.9 billion R&D budget as percentage of revenue: 18.2%
  7. GlaxoSmithKline R&D budget:£5.52 billion ($7.7 billion) R&D budget as percentage of revenue: 16.1%
  8. Sanofi R&D budget:€5.52 billion ($6.6 billion) R&D budget as percentage of revenue:15.3%
  9. AbbVie R&D budget:$6.55 billion Change from 2019:+$150 million Total 2019 revenue: $45.8 billion R&D budget as percentage of revenue:3%
  10. Eli Lilly R&D budget: $6.08 billion R&D budget as percentage of revenue: 24.8%
//
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, how can I help?
Whatsapp
Scroll to Top